The authors reported that, at baseline, lesions that did not become resistant showed a higher PD-L1 expression, immune cell infiltration, and a high TMB; moreover, PD-L1 expression was also more common in secondary-resistant tumours than in primary-resistant tumours, and in late secondary-resistant tumours than in early resistant tumours. This evidence concerns the gene CD274 and neoplasm.